Glycopeptide Antibiotics
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 64 (9), 913-936
- https://doi.org/10.2165/00003495-200464090-00001
Abstract
Vancomycin and teicoplanin are still the only glycopeptide antibiotics available for use in humans. Emergence of resistance in enterococci and staphylococci has led to restriction of their use to...Keywords
This publication has 157 references indexed in Scilit:
- Rates of Carriage of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus in an Outpatient PopulationInfection Control & Hospital Epidemiology, 2003
- Pneumococcal Susceptibility to Meropenem in a Mid-South Childrenʼs HospitalSouthern Medical Journal, 2002
- Selective Cleavage of D-Ala-D-Lac by Small Molecules: Re-Sensitizing Resistant Bacteria to VancomycinScience, 2001
- Activities of LY333328 and Vancomycin Administered Alone or in Combination with Gentamicin against Three Strains of Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection ModelAntimicrobial Agents and Chemotherapy, 2000
- Clinical Pharmacokinetics of TeicoplaninClinical Pharmacokinetics, 2000
- The Structural Biology of Molecular Recognition by VancomycinAnnual Review of Biophysics, 2000
- Excessive Use of Vancomycin: A Successful Intervention Strategy at an Academic Medical CenterInfection Control & Hospital Epidemiology, 2000
- Selection of Glycopeptide-Resistant Mutants of VanB-Type Enterococcus faecaiis BM4281 In Vitro and in Experimental EndocarditisThe Journal of Infectious Diseases, 1997
- Crystal structure of vancomycinStructure, 1996
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988